MedTrace Logo

Home OCT Repeatability and Reproducibility of Automatic Fluid Quantification Study

NCT05281042 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2022-04-05

No results posted yet for this study

Summary

The study will enroll up to 30 AMD patients diagnosed with NV-AMD in at least one eye at the time of enrollment. At the Study Visit, fluid must be present in at least one eye of the subjects. If only one eye qualifies for enrollment, that will be assigned as the study eye. If both eyes are eligible, the study eye will be assigned according to a randomization schedule. Only one eye of each subject will be enrolled in the study. All subjects will be enrolled at 1 site in the United States. Subjects must meet all inclusion and no exclusion criteria.

Conditions

  • Neovascular Age-related Macular Degeneration

Sponsors & Collaborators

  • Notal Vision Inc.

    lead INDUSTRY

Principal Investigators

  • Gidi Benyamini · Notal vision Druyanov 5, Tel Aviv

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-13
Primary Completion
2021-11-30
Completion
2022-01-05

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05281042 on ClinicalTrials.gov